#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Generalizability of machine learning for classification of schizophrenia based on resting‐state functional MRI data Abstract Machine learning has increasingly been applied to classification of schizophrenia in neuroimaging research.
1-1	0-16	Generalizability	_
1-2	17-19	of	_
1-3	20-27	machine	_
1-4	28-36	learning	_
1-5	37-40	for	_
1-6	41-55	classification	_
1-7	56-58	of	_
1-8	59-72	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-9	73-78	based	_
1-10	79-81	on	_
1-11	82-95	resting‐state	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-12	96-106	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-13	107-110	MRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-14	111-115	data	_
1-15	116-124	Abstract	_
1-16	125-132	Machine	_
1-17	133-141	learning	_
1-18	142-145	has	_
1-19	146-158	increasingly	_
1-20	159-163	been	_
1-21	164-171	applied	_
1-22	172-174	to	_
1-23	175-189	classification	_
1-24	190-192	of	_
1-25	193-206	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-26	207-209	in	_
1-27	210-222	neuroimaging	_
1-28	223-231	research	_
1-29	232-233	.	_

Text=However, direct replication studies and studies seeking to investigate generalizability are scarce.
2-1	234-241	However	_
2-2	242-243	,	_
2-3	244-250	direct	_
2-4	251-262	replication	_
2-5	263-270	studies	_
2-6	271-274	and	_
2-7	275-282	studies	_
2-8	283-290	seeking	_
2-9	291-293	to	_
2-10	294-305	investigate	_
2-11	306-322	generalizability	_
2-12	323-326	are	_
2-13	327-333	scarce	_
2-14	334-335	.	_

Text=To address these issues, we assessed within‐site and between‐site generalizability of a machine learning classification framework which achieved excellent performance in a previous study using two independent resting‐state functional magnetic resonance imaging data sets collected from different sites and scanners.
3-1	336-338	To	_
3-2	339-346	address	_
3-3	347-352	these	_
3-4	353-359	issues	_
3-5	360-361	,	_
3-6	362-364	we	_
3-7	365-373	assessed	_
3-8	374-385	within‐site	_
3-9	386-389	and	_
3-10	390-402	between‐site	_
3-11	403-419	generalizability	_
3-12	420-422	of	_
3-13	423-424	a	_
3-14	425-432	machine	_
3-15	433-441	learning	_
3-16	442-456	classification	_
3-17	457-466	framework	_
3-18	467-472	which	_
3-19	473-481	achieved	_
3-20	482-491	excellent	_
3-21	492-503	performance	_
3-22	504-506	in	_
3-23	507-508	a	_
3-24	509-517	previous	_
3-25	518-523	study	_
3-26	524-529	using	_
3-27	530-533	two	_
3-28	534-545	independent	_
3-29	546-559	resting‐state	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-30	560-570	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-31	571-579	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-32	580-589	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-33	590-597	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-34	598-602	data	_
3-35	603-607	sets	_
3-36	608-617	collected	_
3-37	618-622	from	_
3-38	623-632	different	_
3-39	633-638	sites	_
3-40	639-642	and	_
3-41	643-651	scanners	_
3-42	652-653	.	_

Text=We established within‐site generalizability of the classification framework in the main data set using cross‐validation.
4-1	654-656	We	_
4-2	657-668	established	_
4-3	669-680	within‐site	_
4-4	681-697	generalizability	_
4-5	698-700	of	_
4-6	701-704	the	_
4-7	705-719	classification	_
4-8	720-729	framework	_
4-9	730-732	in	_
4-10	733-736	the	_
4-11	737-741	main	_
4-12	742-746	data	_
4-13	747-750	set	_
4-14	751-756	using	_
4-15	757-773	cross‐validation	_
4-16	774-775	.	_

Text=Then, we trained a model in the main data set and investigated between‐site generalization in the validated data set using external validation.
5-1	776-780	Then	_
5-2	781-782	,	_
5-3	783-785	we	_
5-4	786-793	trained	_
5-5	794-795	a	_
5-6	796-801	model	_
5-7	802-804	in	_
5-8	805-808	the	_
5-9	809-813	main	_
5-10	814-818	data	_
5-11	819-822	set	_
5-12	823-826	and	_
5-13	827-839	investigated	_
5-14	840-852	between‐site	_
5-15	853-867	generalization	_
5-16	868-870	in	_
5-17	871-874	the	_
5-18	875-884	validated	_
5-19	885-889	data	_
5-20	890-893	set	_
5-21	894-899	using	_
5-22	900-908	external	_
5-23	909-919	validation	_
5-24	920-921	.	_

Text=Finally, recognizing the poor between‐site generalization performance, we updated the unsupervised algorithm to investigate if transfer learning using additional unlabeled data were able to improve between‐site classification performance.
6-1	922-929	Finally	_
6-2	930-931	,	_
6-3	932-943	recognizing	_
6-4	944-947	the	_
6-5	948-952	poor	_
6-6	953-965	between‐site	_
6-7	966-980	generalization	_
6-8	981-992	performance	_
6-9	993-994	,	_
6-10	995-997	we	_
6-11	998-1005	updated	_
6-12	1006-1009	the	_
6-13	1010-1022	unsupervised	_
6-14	1023-1032	algorithm	_
6-15	1033-1035	to	_
6-16	1036-1047	investigate	_
6-17	1048-1050	if	_
6-18	1051-1059	transfer	_
6-19	1060-1068	learning	_
6-20	1069-1074	using	_
6-21	1075-1085	additional	_
6-22	1086-1095	unlabeled	_
6-23	1096-1100	data	_
6-24	1101-1105	were	_
6-25	1106-1110	able	_
6-26	1111-1113	to	_
6-27	1114-1121	improve	_
6-28	1122-1134	between‐site	_
6-29	1135-1149	classification	_
6-30	1150-1161	performance	_
6-31	1162-1163	.	_

Text=Cross‐validation showed that the published classification procedure achieved an accuracy of 0.73 using majority voting across all selected components.
7-1	1164-1180	Cross‐validation	_
7-2	1181-1187	showed	_
7-3	1188-1192	that	_
7-4	1193-1196	the	_
7-5	1197-1206	published	_
7-6	1207-1221	classification	_
7-7	1222-1231	procedure	_
7-8	1232-1240	achieved	_
7-9	1241-1243	an	_
7-10	1244-1252	accuracy	_
7-11	1253-1255	of	_
7-12	1256-1260	0.73	_
7-13	1261-1266	using	_
7-14	1267-1275	majority	_
7-15	1276-1282	voting	_
7-16	1283-1289	across	_
7-17	1290-1293	all	_
7-18	1294-1302	selected	_
7-19	1303-1313	components	_
7-20	1314-1315	.	_

Text=External validation found a classification accuracy of 0.55 (not significant) and 0.70 (significant) using the direct and transfer learning procedures, respectively.
8-1	1316-1324	External	_
8-2	1325-1335	validation	_
8-3	1336-1341	found	_
8-4	1342-1343	a	_
8-5	1344-1358	classification	_
8-6	1359-1367	accuracy	_
8-7	1368-1370	of	_
8-8	1371-1375	0.55	_
8-9	1376-1377	(	_
8-10	1378-1381	not	_
8-11	1382-1393	significant	_
8-12	1394-1395	)	_
8-13	1396-1399	and	_
8-14	1400-1404	0.70	_
8-15	1405-1406	(	_
8-16	1407-1418	significant	_
8-17	1419-1420	)	_
8-18	1421-1426	using	_
8-19	1427-1430	the	_
8-20	1431-1437	direct	_
8-21	1438-1441	and	_
8-22	1442-1450	transfer	_
8-23	1451-1459	learning	_
8-24	1460-1470	procedures	_
8-25	1471-1472	,	_
8-26	1473-1485	respectively	_
8-27	1486-1487	.	_

Text=The failure of direct generalization from one site to another demonstrates the limitation of within‐site cross‐validation and points toward the need to incorporate efforts to facilitate application of machine learning across multiple data sets.
9-1	1488-1491	The	_
9-2	1492-1499	failure	_
9-3	1500-1502	of	_
9-4	1503-1509	direct	_
9-5	1510-1524	generalization	_
9-6	1525-1529	from	_
9-7	1530-1533	one	_
9-8	1534-1538	site	_
9-9	1539-1541	to	_
9-10	1542-1549	another	_
9-11	1550-1562	demonstrates	_
9-12	1563-1566	the	_
9-13	1567-1577	limitation	_
9-14	1578-1580	of	_
9-15	1581-1592	within‐site	_
9-16	1593-1609	cross‐validation	_
9-17	1610-1613	and	_
9-18	1614-1620	points	_
9-19	1621-1627	toward	_
9-20	1628-1631	the	_
9-21	1632-1636	need	_
9-22	1637-1639	to	_
9-23	1640-1651	incorporate	_
9-24	1652-1659	efforts	_
9-25	1660-1662	to	_
9-26	1663-1673	facilitate	_
9-27	1674-1685	application	_
9-28	1686-1688	of	_
9-29	1689-1696	machine	_
9-30	1697-1705	learning	_
9-31	1706-1712	across	_
9-32	1713-1721	multiple	_
9-33	1722-1726	data	_
9-34	1727-1731	sets	_
9-35	1732-1733	.	_

Text=The improvement in performance with transfer learning highlights the importance of taking into account the properties of data when constructing predictive models across samples and sites.
10-1	1734-1737	The	_
10-2	1738-1749	improvement	_
10-3	1750-1752	in	_
10-4	1753-1764	performance	_
10-5	1765-1769	with	_
10-6	1770-1778	transfer	_
10-7	1779-1787	learning	_
10-8	1788-1798	highlights	_
10-9	1799-1802	the	_
10-10	1803-1813	importance	_
10-11	1814-1816	of	_
10-12	1817-1823	taking	_
10-13	1824-1828	into	_
10-14	1829-1836	account	_
10-15	1837-1840	the	_
10-16	1841-1851	properties	_
10-17	1852-1854	of	_
10-18	1855-1859	data	_
10-19	1860-1864	when	_
10-20	1865-1877	constructing	_
10-21	1878-1888	predictive	_
10-22	1889-1895	models	_
10-23	1896-1902	across	_
10-24	1903-1910	samples	_
10-25	1911-1914	and	_
10-26	1915-1920	sites	_
10-27	1921-1922	.	_

Text=Our findings suggest that machine learning classification result based on a single study should be interpreted cautiously.
11-1	1923-1926	Our	_
11-2	1927-1935	findings	_
11-3	1936-1943	suggest	_
11-4	1944-1948	that	_
11-5	1949-1956	machine	_
11-6	1957-1965	learning	_
11-7	1966-1980	classification	_
11-8	1981-1987	result	_
11-9	1988-1993	based	_
11-10	1994-1996	on	_
11-11	1997-1998	a	_
11-12	1999-2005	single	_
11-13	2006-2011	study	_
11-14	2012-2018	should	_
11-15	2019-2021	be	_
11-16	2022-2033	interpreted	_
11-17	2034-2044	cautiously	_
11-18	2045-2046	.	_

Text=METHODS Participants Two data sets of patients with schizophrenia and healthy controls were included in this study.
12-1	2047-2054	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
12-2	2055-2067	Participants	_
12-3	2068-2071	Two	_
12-4	2072-2076	data	_
12-5	2077-2081	sets	_
12-6	2082-2084	of	_
12-7	2085-2093	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
12-8	2094-2098	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
12-9	2099-2112	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
12-10	2113-2116	and	_
12-11	2117-2124	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-12	2125-2133	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-13	2134-2138	were	_
12-14	2139-2147	included	_
12-15	2148-2150	in	_
12-16	2151-2155	this	_
12-17	2156-2161	study	_
12-18	2162-2163	.	_

Text=In the main data set, 51 patients with schizophrenia and 51 healthy controls were recruited (Table 2).
13-1	2164-2166	In	_
13-2	2167-2170	the	_
13-3	2171-2175	main	_
13-4	2176-2180	data	_
13-5	2181-2184	set	_
13-6	2185-2186	,	_
13-7	2187-2189	51	_
13-8	2190-2198	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-9	2199-2203	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-10	2204-2217	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-11	2218-2221	and	_
13-12	2222-2224	51	_
13-13	2225-2232	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-14	2233-2241	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-15	2242-2246	were	_
13-16	2247-2256	recruited	_
13-17	2257-2258	(	_
13-18	2259-2264	Table	_
13-19	2265-2266	2	_
13-20	2267-2268	)	_
13-21	2269-2270	.	_

Text=Schizophrenia patients were recruited from the Community Health Service Centre of the Institute of Mental Health (the sixth Affiliated Hospital of Peking University) in the Haidian District of Beijing, China.
14-1	2271-2284	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
14-2	2285-2293	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
14-3	2294-2298	were	_
14-4	2299-2308	recruited	_
14-5	2309-2313	from	_
14-6	2314-2317	the	_
14-7	2318-2327	Community	_
14-8	2328-2334	Health	_
14-9	2335-2342	Service	_
14-10	2343-2349	Centre	_
14-11	2350-2352	of	_
14-12	2353-2356	the	_
14-13	2357-2366	Institute	_
14-14	2367-2369	of	_
14-15	2370-2376	Mental	_
14-16	2377-2383	Health	_
14-17	2384-2385	(	_
14-18	2386-2389	the	_
14-19	2390-2395	sixth	_
14-20	2396-2406	Affiliated	_
14-21	2407-2415	Hospital	_
14-22	2416-2418	of	_
14-23	2419-2425	Peking	_
14-24	2426-2436	University	_
14-25	2437-2438	)	_
14-26	2439-2441	in	_
14-27	2442-2445	the	_
14-28	2446-2453	Haidian	_
14-29	2454-2462	District	_
14-30	2463-2465	of	_
14-31	2466-2473	Beijing	_
14-32	2474-2475	,	_
14-33	2476-2481	China	_
14-34	2482-2483	.	_

Text=In the validated data set, 34 patients with schizophrenia and 27 healthy controls were recruited (Table 2).
15-1	2484-2486	In	_
15-2	2487-2490	the	_
15-3	2491-2500	validated	_
15-4	2501-2505	data	_
15-5	2506-2509	set	_
15-6	2510-2511	,	_
15-7	2512-2514	34	_
15-8	2515-2523	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-9	2524-2528	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-10	2529-2542	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-11	2543-2546	and	_
15-12	2547-2549	27	_
15-13	2550-2557	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
15-14	2558-2566	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
15-15	2567-2571	were	_
15-16	2572-2581	recruited	_
15-17	2582-2583	(	_
15-18	2584-2589	Table	_
15-19	2590-2591	2	_
15-20	2592-2593	)	_
15-21	2594-2595	.	_

Text=The patients with schizophrenia were recruited from the Changsha Psychiatric Hospital, Changsha, Hunan province, China.
16-1	2596-2599	The	_
16-2	2600-2608	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
16-3	2609-2613	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
16-4	2614-2627	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
16-5	2628-2632	were	_
16-6	2633-2642	recruited	_
16-7	2643-2647	from	_
16-8	2648-2651	the	_
16-9	2652-2660	Changsha	_
16-10	2661-2672	Psychiatric	_
16-11	2673-2681	Hospital	_
16-12	2682-2683	,	_
16-13	2684-2692	Changsha	_
16-14	2693-2694	,	_
16-15	2695-2700	Hunan	_
16-16	2701-2709	province	_
16-17	2710-2711	,	_
16-18	2712-2717	China	_
16-19	2718-2719	.	_

Text=The diagnosis of schizophrenia was ascertained with the Structural Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV), Fourth Edition (Frances, 1994).
17-1	2720-2723	The	_
17-2	2724-2733	diagnosis	_
17-3	2734-2736	of	_
17-4	2737-2750	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
17-5	2751-2754	was	_
17-6	2755-2766	ascertained	_
17-7	2767-2771	with	_
17-8	2772-2775	the	_
17-9	2776-2786	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-10	2787-2795	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-11	2796-2805	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-12	2806-2809	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-13	2810-2813	the	_
17-14	2814-2824	Diagnostic	_
17-15	2825-2828	and	_
17-16	2829-2840	Statistical	_
17-17	2841-2847	Manual	http://maven.renci.org/NeuroBridge/neurobridge#MercurySphygmomanometer
17-18	2848-2850	of	_
17-19	2851-2857	Mental	_
17-20	2858-2867	Disorders	_
17-21	2868-2869	(	_
17-22	2870-2876	DSM‐IV	_
17-23	2877-2878	)	_
17-24	2879-2880	,	_
17-25	2881-2887	Fourth	_
17-26	2888-2895	Edition	_
17-27	2896-2897	(	_
17-28	2898-2905	Frances	_
17-29	2906-2907	,	_
17-30	2908-2912	1994	_
17-31	2913-2914	)	_
17-32	2915-2916	.	_

Text=The Positive and Negative Syndrome Scale (PANSS) (Kay, Fiszbein, & Opler, 1987) was used to assess the severity of schizophrenia symptoms.
18-1	2917-2920	The	_
18-2	2921-2929	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-3	2930-2933	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-4	2934-2942	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-5	2943-2951	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-6	2952-2957	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-7	2958-2959	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-8	2960-2965	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-9	2966-2967	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
18-10	2968-2969	(	_
18-11	2970-2973	Kay	_
18-12	2974-2975	,	_
18-13	2976-2984	Fiszbein	_
18-14	2985-2986	,	_
18-15	2987-2988	&	_
18-16	2989-2994	Opler	_
18-17	2995-2996	,	_
18-18	2997-3001	1987	_
18-19	3002-3003	)	_
18-20	3004-3007	was	_
18-21	3008-3012	used	_
18-22	3013-3015	to	_
18-23	3016-3022	assess	_
18-24	3023-3026	the	_
18-25	3027-3035	severity	_
18-26	3036-3038	of	_
18-27	3039-3052	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-28	3053-3061	symptoms	_
18-29	3062-3063	.	_

Text=Both the clinical assessment and the diagnostic interviews were conducted by experienced psychiatrists.
19-1	3064-3068	Both	_
19-2	3069-3072	the	_
19-3	3073-3081	clinical	_
19-4	3082-3092	assessment	_
19-5	3093-3096	and	_
19-6	3097-3100	the	_
19-7	3101-3111	diagnostic	_
19-8	3112-3122	interviews	_
19-9	3123-3127	were	_
19-10	3128-3137	conducted	_
19-11	3138-3140	by	_
19-12	3141-3152	experienced	_
19-13	3153-3166	psychiatrists	_
19-14	3167-3168	.	_

Text=All patients were taking antipsychotic medications.
20-1	3169-3172	All	_
20-2	3173-3181	patients	_
20-3	3182-3186	were	_
20-4	3187-3193	taking	_
20-5	3194-3207	antipsychotic	_
20-6	3208-3219	medications	_
20-7	3220-3221	.	_

Text=Healthy controls were recruited from the local community via advertisements.
21-1	3222-3229	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
21-2	3230-3238	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
21-3	3239-3243	were	_
21-4	3244-3253	recruited	_
21-5	3254-3258	from	_
21-6	3259-3262	the	_
21-7	3263-3268	local	_
21-8	3269-3278	community	_
21-9	3279-3282	via	_
21-10	3283-3297	advertisements	_
21-11	3298-3299	.	_

Text=They had no personal and family history of mental disorders.
22-1	3300-3304	They	_
22-2	3305-3308	had	_
22-3	3309-3311	no	_
22-4	3312-3320	personal	_
22-5	3321-3324	and	_
22-6	3325-3331	family	_
22-7	3332-3339	history	_
22-8	3340-3342	of	_
22-9	3343-3349	mental	_
22-10	3350-3359	disorders	_
22-11	3360-3361	.	_

Text=Participants with neurological disorders, substance abuse, and/or dependence or head injuries were excluded.
23-1	3362-3374	Participants	_
23-2	3375-3379	with	_
23-3	3380-3392	neurological	_
23-4	3393-3402	disorders	_
23-5	3403-3404	,	_
23-6	3405-3414	substance	_
23-7	3415-3420	abuse	_
23-8	3421-3422	,	_
23-9	3423-3429	and/or	_
23-10	3430-3440	dependence	_
23-11	3441-3443	or	_
23-12	3444-3448	head	_
23-13	3449-3457	injuries	_
23-14	3458-3462	were	_
23-15	3463-3471	excluded	_
23-16	3472-3473	.	_

Text=The short form of the Chinese version of the Wechsler Adult Intelligence Scale (Gong, 1992) was used to estimate the IQ of all participants.
24-1	3474-3477	The	_
24-2	3478-3483	short	_
24-3	3484-3488	form	_
24-4	3489-3491	of	_
24-5	3492-3495	the	_
24-6	3496-3503	Chinese	_
24-7	3504-3511	version	_
24-8	3512-3514	of	_
24-9	3515-3518	the	_
24-10	3519-3527	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
24-11	3528-3533	Adult	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
24-12	3534-3546	Intelligence	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
24-13	3547-3552	Scale	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
24-14	3553-3554	(	_
24-15	3555-3559	Gong	_
24-16	3560-3561	,	_
24-17	3562-3566	1992	_
24-18	3567-3568	)	_
24-19	3569-3572	was	_
24-20	3573-3577	used	_
24-21	3578-3580	to	_
24-22	3581-3589	estimate	_
24-23	3590-3593	the	_
24-24	3594-3596	IQ	_
24-25	3597-3599	of	_
24-26	3600-3603	all	_
24-27	3604-3616	participants	_
24-28	3617-3618	.	_

Text=In addition, independent sample t tests were conducted to compare age, length of education and estimated IQ between the two healthy control groups (Table 3), and the same were conducted to compare onset age, duration of illness and severity of psychotic symptoms between the two patient groups.
25-1	3619-3621	In	_
25-2	3622-3630	addition	_
25-3	3631-3632	,	_
25-4	3633-3644	independent	_
25-5	3645-3651	sample	_
25-6	3652-3653	t	_
25-7	3654-3659	tests	_
25-8	3660-3664	were	_
25-9	3665-3674	conducted	_
25-10	3675-3677	to	_
25-11	3678-3685	compare	_
25-12	3686-3689	age	_
25-13	3690-3691	,	_
25-14	3692-3698	length	_
25-15	3699-3701	of	_
25-16	3702-3711	education	_
25-17	3712-3715	and	_
25-18	3716-3725	estimated	_
25-19	3726-3728	IQ	_
25-20	3729-3736	between	_
25-21	3737-3740	the	_
25-22	3741-3744	two	_
25-23	3745-3752	healthy	_
25-24	3753-3760	control	_
25-25	3761-3767	groups	_
25-26	3768-3769	(	_
25-27	3770-3775	Table	_
25-28	3776-3777	3	_
25-29	3778-3779	)	_
25-30	3780-3781	,	_
25-31	3782-3785	and	_
25-32	3786-3789	the	_
25-33	3790-3794	same	_
25-34	3795-3799	were	_
25-35	3800-3809	conducted	_
25-36	3810-3812	to	_
25-37	3813-3820	compare	_
25-38	3821-3826	onset	_
25-39	3827-3830	age	_
25-40	3831-3832	,	_
25-41	3833-3841	duration	_
25-42	3842-3844	of	_
25-43	3845-3852	illness	_
25-44	3853-3856	and	_
25-45	3857-3865	severity	_
25-46	3866-3868	of	_
25-47	3869-3878	psychotic	_
25-48	3879-3887	symptoms	_
25-49	3888-3895	between	_
25-50	3896-3899	the	_
25-51	3900-3903	two	_
25-52	3904-3911	patient	_
25-53	3912-3918	groups	_
25-54	3919-3920	.	_

Text=Chi‐square tests were also used to compare the gender proportion between the two healthy control groups and the two clinical groups.
26-1	3921-3931	Chi‐square	_
26-2	3932-3937	tests	_
26-3	3938-3942	were	_
26-4	3943-3947	also	_
26-5	3948-3952	used	_
26-6	3953-3955	to	_
26-7	3956-3963	compare	_
26-8	3964-3967	the	_
26-9	3968-3974	gender	_
26-10	3975-3985	proportion	_
26-11	3986-3993	between	_
26-12	3994-3997	the	_
26-13	3998-4001	two	_
26-14	4002-4009	healthy	_
26-15	4010-4017	control	_
26-16	4018-4024	groups	_
26-17	4025-4028	and	_
26-18	4029-4032	the	_
26-19	4033-4036	two	_
26-20	4037-4045	clinical	_
26-21	4046-4052	groups	_
26-22	4053-4054	.	_

Text=Finally, a five‐factor model of the PANSS (Anderson et al., 2017; Lindenmayer, Grochowski, & Hyman, 1995) comprising negative, positive, disorganized, excited, and anxiety symptom domains was computed and compared between the two clinical groups (Table 3).
27-1	4055-4062	Finally	_
27-2	4063-4064	,	_
27-3	4065-4066	a	_
27-4	4067-4078	five‐factor	_
27-5	4079-4084	model	_
27-6	4085-4087	of	_
27-7	4088-4091	the	_
27-8	4092-4097	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
27-9	4098-4099	(	_
27-10	4100-4108	Anderson	_
27-11	4109-4111	et	_
27-12	4112-4115	al.	_
27-13	4116-4117	,	_
27-14	4118-4122	2017	_
27-15	4123-4124	;	_
27-16	4125-4136	Lindenmayer	_
27-17	4137-4138	,	_
27-18	4139-4149	Grochowski	_
27-19	4150-4151	,	_
27-20	4152-4153	&	_
27-21	4154-4159	Hyman	_
27-22	4160-4161	,	_
27-23	4162-4166	1995	_
27-24	4167-4168	)	_
27-25	4169-4179	comprising	_
27-26	4180-4188	negative	_
27-27	4189-4190	,	_
27-28	4191-4199	positive	_
27-29	4200-4201	,	_
27-30	4202-4214	disorganized	_
27-31	4215-4216	,	_
27-32	4217-4224	excited	_
27-33	4225-4226	,	_
27-34	4227-4230	and	_
27-35	4231-4238	anxiety	_
27-36	4239-4246	symptom	_
27-37	4247-4254	domains	_
27-38	4255-4258	was	_
27-39	4259-4267	computed	_
27-40	4268-4271	and	_
27-41	4272-4280	compared	_
27-42	4281-4288	between	_
27-43	4289-4292	the	_
27-44	4293-4296	two	_
27-45	4297-4305	clinical	_
27-46	4306-4312	groups	_
27-47	4313-4314	(	_
27-48	4315-4320	Table	_
27-49	4321-4322	3	_
27-50	4323-4324	)	_
27-51	4325-4326	.	_

Text=The study was approved by the Ethics Committee of the Institute of Psychology, the Chinese Academy of Sciences.
28-1	4327-4330	The	_
28-2	4331-4336	study	_
28-3	4337-4340	was	_
28-4	4341-4349	approved	_
28-5	4350-4352	by	_
28-6	4353-4356	the	_
28-7	4357-4363	Ethics	_
28-8	4364-4373	Committee	_
28-9	4374-4376	of	_
28-10	4377-4380	the	_
28-11	4381-4390	Institute	_
28-12	4391-4393	of	_
28-13	4394-4404	Psychology	_
28-14	4405-4406	,	_
28-15	4407-4410	the	_
28-16	4411-4418	Chinese	_
28-17	4419-4426	Academy	_
28-18	4427-4429	of	_
28-19	4430-4438	Sciences	_
28-20	4439-4440	.	_

Text=All participants gave written informed consent.
29-1	4441-4444	All	_
29-2	4445-4457	participants	_
29-3	4458-4462	gave	_
29-4	4463-4470	written	_
29-5	4471-4479	informed	_
29-6	4480-4487	consent	_
29-7	4488-4489	.	_

Text=Image acquisition For the main data set, all participants were scanned in a 3‐T Siemens Tim Trio scanner at the Chaoyang Hospital, Beijing, China.
30-1	4490-4495	Image	_
30-2	4496-4507	acquisition	_
30-3	4508-4511	For	_
30-4	4512-4515	the	_
30-5	4516-4520	main	_
30-6	4521-4525	data	_
30-7	4526-4529	set	_
30-8	4530-4531	,	_
30-9	4532-4535	all	_
30-10	4536-4548	participants	_
30-11	4549-4553	were	_
30-12	4554-4561	scanned	_
30-13	4562-4564	in	_
30-14	4565-4566	a	_
30-15	4567-4570	3‐T	_
30-16	4571-4578	Siemens	_
30-17	4579-4582	Tim	_
30-18	4583-4587	Trio	_
30-19	4588-4595	scanner	_
30-20	4596-4598	at	_
30-21	4599-4602	the	_
30-22	4603-4611	Chaoyang	_
30-23	4612-4620	Hospital	_
30-24	4621-4622	,	_
30-25	4623-4630	Beijing	_
30-26	4631-4632	,	_
30-27	4633-4638	China	_
30-28	4639-4640	.	_

Text=The rsfMRI data were collected by an echo‐planar imaging (EPI) sequence utilizing gradient echo.
31-1	4641-4644	The	_
31-2	4645-4651	rsfMRI	http://maven.renci.org/NeuroBridge/neurobridge#Thing
31-3	4652-4656	data	_
31-4	4657-4661	were	_
31-5	4662-4671	collected	_
31-6	4672-4674	by	_
31-7	4675-4677	an	_
31-8	4678-4689	echo‐planar	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
31-9	4690-4697	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
31-10	4698-4699	(	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
31-11	4700-4703	EPI	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
31-12	4704-4705	)	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
31-13	4706-4714	sequence	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
31-14	4715-4724	utilizing	_
31-15	4725-4733	gradient	_
31-16	4734-4738	echo	_
31-17	4739-4740	.	_

Text=Slices were acquired in interleaved order and the data consisted of 200 whole‐brain volumes (repetition time (TR) = 2,500 ms, echo time (TE) = 21 ms, flip angle = 90°, slice number = 42, slice thickness = 3.5 mm, matrix size = 64 × 64, field of view (FOV) = 200 mm, and voxel size = 3.1 × 3.1 × 3.5 mm3).
32-1	4741-4747	Slices	_
32-2	4748-4752	were	_
32-3	4753-4761	acquired	_
32-4	4762-4764	in	_
32-5	4765-4776	interleaved	_
32-6	4777-4782	order	_
32-7	4783-4786	and	_
32-8	4787-4790	the	_
32-9	4791-4795	data	_
32-10	4796-4805	consisted	_
32-11	4806-4808	of	_
32-12	4809-4812	200	_
32-13	4813-4824	whole‐brain	_
32-14	4825-4832	volumes	_
32-15	4833-4834	(	_
32-16	4835-4845	repetition	_
32-17	4846-4850	time	_
32-18	4851-4852	(	_
32-19	4853-4855	TR	_
32-20	4856-4857	)	_
32-21	4858-4859	=	_
32-22	4860-4865	2,500	_
32-23	4866-4868	ms	_
32-24	4869-4870	,	_
32-25	4871-4875	echo	_
32-26	4876-4880	time	_
32-27	4881-4882	(	_
32-28	4883-4885	TE	_
32-29	4886-4887	)	_
32-30	4888-4889	=	_
32-31	4890-4892	21	_
32-32	4893-4895	ms	_
32-33	4896-4897	,	_
32-34	4898-4902	flip	_
32-35	4903-4908	angle	_
32-36	4909-4910	=	_
32-37	4911-4914	90°	_
32-38	4915-4916	,	_
32-39	4917-4922	slice	_
32-40	4923-4929	number	_
32-41	4930-4931	=	_
32-42	4932-4934	42	_
32-43	4935-4936	,	_
32-44	4937-4942	slice	_
32-45	4943-4952	thickness	_
32-46	4953-4954	=	_
32-47	4955-4958	3.5	_
32-48	4959-4961	mm	_
32-49	4962-4963	,	_
32-50	4964-4970	matrix	_
32-51	4971-4975	size	_
32-52	4976-4977	=	_
32-53	4978-4980	64	_
32-54	4981-4982	×	_
32-55	4983-4985	64	_
32-56	4986-4987	,	_
32-57	4988-4993	field	_
32-58	4994-4996	of	_
32-59	4997-5001	view	_
32-60	5002-5003	(	_
32-61	5004-5007	FOV	_
32-62	5008-5009	)	_
32-63	5010-5011	=	_
32-64	5012-5015	200	_
32-65	5016-5018	mm	_
32-66	5019-5020	,	_
32-67	5021-5024	and	_
32-68	5025-5030	voxel	_
32-69	5031-5035	size	_
32-70	5036-5037	=	_
32-71	5038-5041	3.1	_
32-72	5042-5043	×	_
32-73	5044-5047	3.1	_
32-74	5048-5049	×	_
32-75	5050-5053	3.5	_
32-76	5054-5057	mm3	_
32-77	5058-5059	)	_
32-78	5060-5061	.	_

Text=T1‐weighted structural image data were collected for anatomical reference using a 3D magnetization‐prepared rapid gradient‐echo (MPRAGE) sequence (TR = 2,530 ms, TE = 2.34 ms, flip angle = 7°, FOV = 256 mm, slice thickness = 1 mm, slice number = 176, in‐plane matrix resolution = 256 × 256, and voxel size = 1 × 1 × 1 mm3).
33-1	5062-5073	T1‐weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
33-2	5074-5084	structural	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
33-3	5085-5090	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
33-4	5091-5095	data	_
33-5	5096-5100	were	_
33-6	5101-5110	collected	_
33-7	5111-5114	for	_
33-8	5115-5125	anatomical	_
33-9	5126-5135	reference	_
33-10	5136-5141	using	_
33-11	5142-5143	a	_
33-12	5144-5146	3D	_
33-13	5147-5169	magnetization‐prepared	_
33-14	5170-5175	rapid	_
33-15	5176-5189	gradient‐echo	_
33-16	5190-5191	(	http://maven.renci.org/NeuroBridge/neurobridge#Age
33-17	5192-5198	MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#Age
33-18	5199-5200	)	http://maven.renci.org/NeuroBridge/neurobridge#Age
33-19	5201-5209	sequence	_
33-20	5210-5211	(	_
33-21	5212-5214	TR	_
33-22	5215-5216	=	_
33-23	5217-5222	2,530	_
33-24	5223-5225	ms	_
33-25	5226-5227	,	_
33-26	5228-5230	TE	_
33-27	5231-5232	=	_
33-28	5233-5237	2.34	_
33-29	5238-5240	ms	_
33-30	5241-5242	,	_
33-31	5243-5247	flip	_
33-32	5248-5253	angle	_
33-33	5254-5255	=	_
33-34	5256-5258	7°	_
33-35	5259-5260	,	_
33-36	5261-5264	FOV	_
33-37	5265-5266	=	_
33-38	5267-5270	256	_
33-39	5271-5273	mm	_
33-40	5274-5275	,	_
33-41	5276-5281	slice	_
33-42	5282-5291	thickness	_
33-43	5292-5293	=	_
33-44	5294-5295	1	_
33-45	5296-5298	mm	_
33-46	5299-5300	,	_
33-47	5301-5306	slice	_
33-48	5307-5313	number	_
33-49	5314-5315	=	_
33-50	5316-5319	176	_
33-51	5320-5321	,	_
33-52	5322-5330	in‐plane	_
33-53	5331-5337	matrix	_
33-54	5338-5348	resolution	_
33-55	5349-5350	=	_
33-56	5351-5354	256	_
33-57	5355-5356	×	_
33-58	5357-5360	256	_
33-59	5361-5362	,	_
33-60	5363-5366	and	_
33-61	5367-5372	voxel	_
33-62	5373-5377	size	_
33-63	5378-5379	=	_
33-64	5380-5381	1	_
33-65	5382-5383	×	_
33-66	5384-5385	1	_
33-67	5386-5387	×	_
33-68	5388-5389	1	_
33-69	5390-5393	mm3	_
33-70	5394-5395	)	_
33-71	5396-5397	.	_

Text=For the validated data set, all participants were scanned in a 3‐T Siemens TIM Trio scanner in the Hunan Provincial People's Hospital, Changsha, Hunan province, China.
34-1	5398-5401	For	_
34-2	5402-5405	the	_
34-3	5406-5415	validated	_
34-4	5416-5420	data	_
34-5	5421-5424	set	_
34-6	5425-5426	,	_
34-7	5427-5430	all	_
34-8	5431-5443	participants	_
34-9	5444-5448	were	_
34-10	5449-5456	scanned	_
34-11	5457-5459	in	_
34-12	5460-5461	a	_
34-13	5462-5465	3‐T	http://maven.renci.org/NeuroBridge/neurobridge#2Level
34-14	5466-5473	Siemens	http://maven.renci.org/NeuroBridge/neurobridge#2Level
34-15	5474-5477	TIM	http://maven.renci.org/NeuroBridge/neurobridge#2Level
34-16	5478-5482	Trio	_
34-17	5483-5490	scanner	_
34-18	5491-5493	in	_
34-19	5494-5497	the	_
34-20	5498-5503	Hunan	_
34-21	5504-5514	Provincial	_
34-22	5515-5521	People	_
34-23	5522-5524	's	_
34-24	5525-5533	Hospital	_
34-25	5534-5535	,	_
34-26	5536-5544	Changsha	_
34-27	5545-5546	,	_
34-28	5547-5552	Hunan	_
34-29	5553-5561	province	_
34-30	5562-5563	,	_
34-31	5564-5569	China	_
34-32	5570-5571	.	_

Text=The rsfMRI data were collected by an EPI sequence utilizing gradient echo.
35-1	5572-5575	The	_
35-2	5576-5582	rsfMRI	http://maven.renci.org/NeuroBridge/neurobridge#Thing
35-3	5583-5587	data	_
35-4	5588-5592	were	_
35-5	5593-5602	collected	_
35-6	5603-5605	by	_
35-7	5606-5608	an	_
35-8	5609-5612	EPI	_
35-9	5613-5621	sequence	_
35-10	5622-5631	utilizing	_
35-11	5632-5640	gradient	_
35-12	5641-5645	echo	_
35-13	5646-5647	.	_

Text=Slices were acquired in interleaved order and the data consisted of 180 whole‐brain volumes (TR = 2,000 ms, TE = 25 ms, flip angle = 80°, slice number = 32, slice thickness = 4.5 mm, matrix size = 64 × 64, FOV = 240 mm, and voxel size = 3.75 × 3.75 × 4.5 mm3).
36-1	5648-5654	Slices	_
36-2	5655-5659	were	_
36-3	5660-5668	acquired	_
36-4	5669-5671	in	_
36-5	5672-5683	interleaved	_
36-6	5684-5689	order	_
36-7	5690-5693	and	_
36-8	5694-5697	the	_
36-9	5698-5702	data	_
36-10	5703-5712	consisted	_
36-11	5713-5715	of	_
36-12	5716-5719	180	_
36-13	5720-5731	whole‐brain	_
36-14	5732-5739	volumes	_
36-15	5740-5741	(	_
36-16	5742-5744	TR	_
36-17	5745-5746	=	_
36-18	5747-5752	2,000	_
36-19	5753-5755	ms	_
36-20	5756-5757	,	_
36-21	5758-5760	TE	_
36-22	5761-5762	=	_
36-23	5763-5765	25	_
36-24	5766-5768	ms	_
36-25	5769-5770	,	_
36-26	5771-5775	flip	_
36-27	5776-5781	angle	_
36-28	5782-5783	=	_
36-29	5784-5787	80°	_
36-30	5788-5789	,	_
36-31	5790-5795	slice	_
36-32	5796-5802	number	_
36-33	5803-5804	=	_
36-34	5805-5807	32	_
36-35	5808-5809	,	_
36-36	5810-5815	slice	_
36-37	5816-5825	thickness	_
36-38	5826-5827	=	_
36-39	5828-5831	4.5	_
36-40	5832-5834	mm	_
36-41	5835-5836	,	_
36-42	5837-5843	matrix	_
36-43	5844-5848	size	_
36-44	5849-5850	=	_
36-45	5851-5853	64	_
36-46	5854-5855	×	_
36-47	5856-5858	64	_
36-48	5859-5860	,	_
36-49	5861-5864	FOV	_
36-50	5865-5866	=	_
36-51	5867-5870	240	_
36-52	5871-5873	mm	_
36-53	5874-5875	,	_
36-54	5876-5879	and	_
36-55	5880-5885	voxel	_
36-56	5886-5890	size	_
36-57	5891-5892	=	_
36-58	5893-5897	3.75	_
36-59	5898-5899	×	_
36-60	5900-5904	3.75	_
36-61	5905-5906	×	_
36-62	5907-5910	4.5	_
36-63	5911-5914	mm3	_
36-64	5915-5916	)	_
36-65	5917-5918	.	_

Text=T1‐weighted structural image data were collected using a 3D MPRAGE sequence (TR = 2,000 ms, TE = 2.26 ms, flip angle = 8°, FOV = 256 mm, slice thickness = 1 mm, slice number = 176, in‐plane matrix resolution = 256 × 256, and voxel size = 1 × 1 × 1 mm3).
37-1	5919-5930	T1‐weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
37-2	5931-5941	structural	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
37-3	5942-5947	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
37-4	5948-5952	data	_
37-5	5953-5957	were	_
37-6	5958-5967	collected	_
37-7	5968-5973	using	_
37-8	5974-5975	a	_
37-9	5976-5978	3D	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
37-10	5979-5985	MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
37-11	5986-5994	sequence	_
37-12	5995-5996	(	_
37-13	5997-5999	TR	_
37-14	6000-6001	=	_
37-15	6002-6007	2,000	_
37-16	6008-6010	ms	_
37-17	6011-6012	,	_
37-18	6013-6015	TE	_
37-19	6016-6017	=	_
37-20	6018-6022	2.26	_
37-21	6023-6025	ms	_
37-22	6026-6027	,	_
37-23	6028-6032	flip	_
37-24	6033-6038	angle	_
37-25	6039-6040	=	_
37-26	6041-6043	8°	_
37-27	6044-6045	,	_
37-28	6046-6049	FOV	_
37-29	6050-6051	=	_
37-30	6052-6055	256	_
37-31	6056-6058	mm	_
37-32	6059-6060	,	_
37-33	6061-6066	slice	_
37-34	6067-6076	thickness	_
37-35	6077-6078	=	_
37-36	6079-6080	1	_
37-37	6081-6083	mm	_
37-38	6084-6085	,	_
37-39	6086-6091	slice	_
37-40	6092-6098	number	_
37-41	6099-6100	=	_
37-42	6101-6104	176	_
37-43	6105-6106	,	_
37-44	6107-6115	in‐plane	_
37-45	6116-6122	matrix	_
37-46	6123-6133	resolution	_
37-47	6134-6135	=	_
37-48	6136-6139	256	_
37-49	6140-6141	×	_
37-50	6142-6145	256	_
37-51	6146-6147	,	_
37-52	6148-6151	and	_
37-53	6152-6157	voxel	_
37-54	6158-6162	size	_
37-55	6163-6164	=	_
37-56	6165-6166	1	_
37-57	6167-6168	×	_
37-58	6169-6170	1	_
37-59	6171-6172	×	_
37-60	6173-6174	1	_
37-61	6175-6178	mm3	_
37-62	6179-6180	)	_
37-63	6181-6182	.	_

Text=While participants were in the scanner, they were asked to remain as stationary as possible and their heads were stabilized with foam pads.
38-1	6183-6188	While	_
38-2	6189-6201	participants	_
38-3	6202-6206	were	_
38-4	6207-6209	in	_
38-5	6210-6213	the	_
38-6	6214-6221	scanner	_
38-7	6222-6223	,	_
38-8	6224-6228	they	_
38-9	6229-6233	were	_
38-10	6234-6239	asked	_
38-11	6240-6242	to	_
38-12	6243-6249	remain	_
38-13	6250-6252	as	_
38-14	6253-6263	stationary	_
38-15	6264-6266	as	_
38-16	6267-6275	possible	_
38-17	6276-6279	and	_
38-18	6280-6285	their	_
38-19	6286-6291	heads	_
38-20	6292-6296	were	_
38-21	6297-6307	stabilized	_
38-22	6308-6312	with	_
38-23	6313-6317	foam	_
38-24	6318-6322	pads	_
38-25	6323-6324	.	_

Text=Data preprocessing Image preprocessing was conducted with the Statistical Parameter Mapping (SPM) software (SPM12; http: //www.fil.ion.ucl.ac.uk/spm/software/spm12), Data Processing Assistant for Resting‐State fMRI (DPARSF) Software (DPARSF4.3; http: //rfmri.org/DPARSF), and a plugin‐in for SPM named Temporal Filter (http: //www.brain-fmri.com/tempfilter) (Madsen, Krohne, Cai, Wang, & Chan, 2018).
39-1	6325-6329	Data	_
39-2	6330-6343	preprocessing	_
39-3	6344-6349	Image	_
39-4	6350-6363	preprocessing	_
39-5	6364-6367	was	_
39-6	6368-6377	conducted	_
39-7	6378-6382	with	_
39-8	6383-6386	the	_
39-9	6387-6398	Statistical	_
39-10	6399-6408	Parameter	_
39-11	6409-6416	Mapping	_
39-12	6417-6418	(	_
39-13	6419-6422	SPM	_
39-14	6423-6424	)	_
39-15	6425-6433	software	_
39-16	6434-6435	(	_
39-17	6436-6441	SPM12	_
39-18	6442-6443	;	_
39-19	6444-6448	http	_
39-20	6449-6450	:	_
39-21	6451-6493	//www.fil.ion.ucl.ac.uk/spm/software/spm12	_
39-22	6494-6495	)	_
39-23	6496-6497	,	_
39-24	6498-6502	Data	_
39-25	6503-6513	Processing	_
39-26	6514-6523	Assistant	_
39-27	6524-6527	for	_
39-28	6528-6541	Resting‐State	_
39-29	6542-6546	fMRI	_
39-30	6547-6548	(	_
39-31	6549-6555	DPARSF	_
39-32	6556-6557	)	_
39-33	6558-6566	Software	_
39-34	6567-6568	(	_
39-35	6569-6578	DPARSF4.3	_
39-36	6579-6580	;	_
39-37	6581-6585	http	_
39-38	6586-6587	:	_
39-39	6588-6606	//rfmri.org/DPARSF	_
39-40	6607-6608	)	_
39-41	6609-6610	,	_
39-42	6611-6614	and	_
39-43	6615-6616	a	_
39-44	6617-6626	plugin‐in	_
39-45	6627-6630	for	_
39-46	6631-6634	SPM	_
39-47	6635-6640	named	_
39-48	6641-6649	Temporal	_
39-49	6650-6656	Filter	_
39-50	6657-6658	(	_
39-51	6659-6663	http	_
39-52	6664-6665	:	_
39-53	6666-6697	//www.brain-fmri.com/tempfilter	_
39-54	6698-6699	)	_
39-55	6700-6701	(	_
39-56	6702-6708	Madsen	_
39-57	6709-6710	,	_
39-58	6711-6717	Krohne	_
39-59	6718-6719	,	_
39-60	6720-6723	Cai	_
39-61	6724-6725	,	_
39-62	6726-6730	Wang	_
39-63	6731-6732	,	_
39-64	6733-6734	&	_
39-65	6735-6739	Chan	_
39-66	6740-6741	,	_
39-67	6742-6746	2018	_
39-68	6747-6748	)	_
39-69	6749-6750	.	_

Text=The two data sets were preprocessed separately with the same steps.
40-1	6751-6754	The	_
40-2	6755-6758	two	_
40-3	6759-6763	data	_
40-4	6764-6768	sets	_
40-5	6769-6773	were	_
40-6	6774-6786	preprocessed	_
40-7	6787-6797	separately	_
40-8	6798-6802	with	_
40-9	6803-6806	the	_
40-10	6807-6811	same	_
40-11	6812-6817	steps	_
40-12	6818-6819	.	_

Text=To avoid T1 relaxation effects prior to equilibrium, the first five volumes of each resting state scan were excluded.
41-1	6820-6822	To	_
41-2	6823-6828	avoid	_
41-3	6829-6831	T1	_
41-4	6832-6842	relaxation	_
41-5	6843-6850	effects	_
41-6	6851-6856	prior	_
41-7	6857-6859	to	_
41-8	6860-6871	equilibrium	_
41-9	6872-6873	,	_
41-10	6874-6877	the	_
41-11	6878-6883	first	_
41-12	6884-6888	five	_
41-13	6889-6896	volumes	_
41-14	6897-6899	of	_
41-15	6900-6904	each	_
41-16	6905-6912	resting	_
41-17	6913-6918	state	_
41-18	6919-6923	scan	_
41-19	6924-6928	were	_
41-20	6929-6937	excluded	_
41-21	6938-6939	.	_

Text=Then, the remaining volumes for each of the functional imaging sessions were processed using DPARSF, including slice timing, realignment, and coregistration to the structural images.
42-1	6940-6944	Then	_
42-2	6945-6946	,	_
42-3	6947-6950	the	_
42-4	6951-6960	remaining	_
42-5	6961-6968	volumes	_
42-6	6969-6972	for	_
42-7	6973-6977	each	_
42-8	6978-6980	of	_
42-9	6981-6984	the	_
42-10	6985-6995	functional	_
42-11	6996-7003	imaging	_
42-12	7004-7012	sessions	_
42-13	7013-7017	were	_
42-14	7018-7027	processed	_
42-15	7028-7033	using	_
42-16	7034-7040	DPARSF	_
42-17	7041-7042	,	_
42-18	7043-7052	including	_
42-19	7053-7058	slice	_
42-20	7059-7065	timing	_
42-21	7066-7067	,	_
42-22	7068-7079	realignment	_
42-23	7080-7081	,	_
42-24	7082-7085	and	_
42-25	7086-7100	coregistration	_
42-26	7101-7103	to	_
42-27	7104-7107	the	_
42-28	7108-7118	structural	_
42-29	7119-7125	images	_
42-30	7126-7127	.	_

Text=Mean frame‐wise displacement (FD) was calculated (Power, Barnes, Snyder, Schlaggar, & Petersen, 2012) for each participant.
43-1	7128-7132	Mean	_
43-2	7133-7143	frame‐wise	_
43-3	7144-7156	displacement	_
43-4	7157-7158	(	_
43-5	7159-7161	FD	_
43-6	7162-7163	)	_
43-7	7164-7167	was	_
43-8	7168-7178	calculated	_
43-9	7179-7180	(	_
43-10	7181-7186	Power	_
43-11	7187-7188	,	_
43-12	7189-7195	Barnes	_
43-13	7196-7197	,	_
43-14	7198-7204	Snyder	_
43-15	7205-7206	,	_
43-16	7207-7216	Schlaggar	_
43-17	7217-7218	,	_
43-18	7219-7220	&	_
43-19	7221-7229	Petersen	_
43-20	7230-7231	,	_
43-21	7232-7236	2012	_
43-22	7237-7238	)	_
43-23	7239-7242	for	_
43-24	7243-7247	each	_
43-25	7248-7259	participant	_
43-26	7260-7261	.	_

Text=The percentage of time points with mean FD power> 0.5 was lower than 10% for all participants.
44-1	7262-7265	The	_
44-2	7266-7276	percentage	_
44-3	7277-7279	of	_
44-4	7280-7284	time	_
44-5	7285-7291	points	_
44-6	7292-7296	with	_
44-7	7297-7301	mean	_
44-8	7302-7304	FD	_
44-9	7305-7310	power	_
44-10	7311-7312	>	_
44-11	7313-7316	0.5	_
44-12	7317-7320	was	_
44-13	7321-7326	lower	_
44-14	7327-7331	than	_
44-15	7332-7334	10	_
44-16	7335-7336	%	_
44-17	7337-7340	for	_
44-18	7341-7344	all	_
44-19	7345-7357	participants	_
44-20	7358-7359	.	_

Text=In order to remove nonstationary signals and other artifacts, the temporal filter toolbox (Madsen et al., 2018) was used.
45-1	7360-7362	In	_
45-2	7363-7368	order	_
45-3	7369-7371	to	_
45-4	7372-7378	remove	_
45-5	7379-7392	nonstationary	_
45-6	7393-7400	signals	_
45-7	7401-7404	and	_
45-8	7405-7410	other	_
45-9	7411-7420	artifacts	_
45-10	7421-7422	,	_
45-11	7423-7426	the	_
45-12	7427-7435	temporal	_
45-13	7436-7442	filter	_
45-14	7443-7450	toolbox	_
45-15	7451-7452	(	_
45-16	7453-7459	Madsen	_
45-17	7460-7462	et	_
45-18	7463-7466	al.	_
45-19	7467-7468	,	_
45-20	7469-7473	2018	_
45-21	7474-7475	)	_
45-22	7476-7479	was	_
45-23	7480-7484	used	_
45-24	7485-7486	.	_

Text=Processing steps included: despiking (Patel et al., 2014), high‐pass filtering and removal of low‐frequency drifts and motion by a 24‐parameter autoregressive model using realignment regressors and scrubbing (using a 1 mm relative movement threshold and a 1% DVARS threshold (Power et al., 2012)) (Friston, Williams, Howard, Frackowiak, & Turner, 1996).
46-1	7487-7497	Processing	_
46-2	7498-7503	steps	_
46-3	7504-7512	included	_
46-4	7513-7514	:	_
46-5	7515-7524	despiking	_
46-6	7525-7526	(	_
46-7	7527-7532	Patel	_
46-8	7533-7535	et	_
46-9	7536-7539	al.	_
46-10	7540-7541	,	_
46-11	7542-7546	2014	_
46-12	7547-7548	)	_
46-13	7549-7550	,	_
46-14	7551-7560	high‐pass	_
46-15	7561-7570	filtering	_
46-16	7571-7574	and	_
46-17	7575-7582	removal	_
46-18	7583-7585	of	_
46-19	7586-7599	low‐frequency	_
46-20	7600-7606	drifts	_
46-21	7607-7610	and	_
46-22	7611-7617	motion	_
46-23	7618-7620	by	_
46-24	7621-7622	a	_
46-25	7623-7635	24‐parameter	_
46-26	7636-7650	autoregressive	_
46-27	7651-7656	model	_
46-28	7657-7662	using	_
46-29	7663-7674	realignment	_
46-30	7675-7685	regressors	_
46-31	7686-7689	and	_
46-32	7690-7699	scrubbing	_
46-33	7700-7701	(	_
46-34	7702-7707	using	_
46-35	7708-7709	a	_
46-36	7710-7711	1	_
46-37	7712-7714	mm	_
46-38	7715-7723	relative	_
46-39	7724-7732	movement	_
46-40	7733-7742	threshold	_
46-41	7743-7746	and	_
46-42	7747-7748	a	_
46-43	7749-7750	1	_
46-44	7751-7752	%	_
46-45	7753-7758	DVARS	_
46-46	7759-7768	threshold	_
46-47	7769-7770	(	_
46-48	7771-7776	Power	_
46-49	7777-7779	et	_
46-50	7780-7783	al.	_
46-51	7784-7785	,	_
46-52	7786-7790	2012	_
46-53	7791-7792	)	_
46-54	7793-7794	)	_
46-55	7795-7796	(	_
46-56	7797-7804	Friston	_
46-57	7805-7806	,	_
46-58	7807-7815	Williams	_
46-59	7816-7817	,	_
46-60	7818-7824	Howard	_
46-61	7825-7826	,	_
46-62	7827-7837	Frackowiak	_
46-63	7838-7839	,	_
46-64	7840-7841	&	_
46-65	7842-7848	Turner	_
46-66	7849-7850	,	_
46-67	7851-7855	1996	_
46-68	7856-7857	)	_
46-69	7858-7859	.	_

Text=Subsequently, spatial normalization with DARTEL was adopted to normalize the functional images into Montreal Neurological Institute (MNI) space (Ashburner, 2009) in SPM12.
47-1	7860-7872	Subsequently	_
47-2	7873-7874	,	_
47-3	7875-7882	spatial	_
47-4	7883-7896	normalization	_
47-5	7897-7901	with	_
47-6	7902-7908	DARTEL	_
47-7	7909-7912	was	_
47-8	7913-7920	adopted	_
47-9	7921-7923	to	_
47-10	7924-7933	normalize	_
47-11	7934-7937	the	_
47-12	7938-7948	functional	_
47-13	7949-7955	images	_
47-14	7956-7960	into	_
47-15	7961-7969	Montreal	_
47-16	7970-7982	Neurological	_
47-17	7983-7992	Institute	_
47-18	7993-7994	(	_
47-19	7995-7998	MNI	_
47-20	7999-8000	)	_
47-21	8001-8006	space	_
47-22	8007-8008	(	_
47-23	8009-8018	Ashburner	_
47-24	8019-8020	,	_
47-25	8021-8025	2009	_
47-26	8026-8027	)	_
47-27	8028-8030	in	_
47-28	8031-8036	SPM12	_
47-29	8037-8038	.	_

Text=Finally, an 8‐mm full‐width‐at‐half‐maximum isotropic Gaussian kernel was used to smooth the functional images (Table 5).
48-1	8039-8046	Finally	_
48-2	8047-8048	,	_
48-3	8049-8051	an	_
48-4	8052-8056	8‐mm	_
48-5	8057-8083	full‐width‐at‐half‐maximum	_
48-6	8084-8093	isotropic	_
48-7	8094-8102	Gaussian	_
48-8	8103-8109	kernel	_
48-9	8110-8113	was	_
48-10	8114-8118	used	_
48-11	8119-8121	to	_
48-12	8122-8128	smooth	_
48-13	8129-8132	the	_
48-14	8133-8143	functional	_
48-15	8144-8150	images	_
48-16	8151-8152	(	_
48-17	8153-8158	Table	_
48-18	8159-8160	5	_
48-19	8161-8162	)	_
48-20	8163-8164	.	_

Text=Machine learning analysis After preprocessing, further machine learning analysis was conducted (see Figure 1 for the analysis flowchart).
49-1	8165-8172	Machine	_
49-2	8173-8181	learning	_
49-3	8182-8190	analysis	_
49-4	8191-8196	After	_
49-5	8197-8210	preprocessing	_
49-6	8211-8212	,	_
49-7	8213-8220	further	_
49-8	8221-8228	machine	_
49-9	8229-8237	learning	_
49-10	8238-8246	analysis	_
49-11	8247-8250	was	_
49-12	8251-8260	conducted	_
49-13	8261-8262	(	_
49-14	8263-8266	see	_
49-15	8267-8273	Figure	_
49-16	8274-8275	1	_
49-17	8276-8279	for	_
49-18	8280-8283	the	_
49-19	8284-8292	analysis	_
49-20	8293-8302	flowchart	_
49-21	8303-8304	)	_
49-22	8305-8306	.	_

Text=To assess generalizability by internal validation, we followed the procedures from Du et al.
50-1	8307-8309	To	_
50-2	8310-8316	assess	_
50-3	8317-8333	generalizability	_
50-4	8334-8336	by	_
50-5	8337-8345	internal	_
50-6	8346-8356	validation	_
50-7	8357-8358	,	_
50-8	8359-8361	we	_
50-9	8362-8370	followed	_
50-10	8371-8374	the	_
50-11	8375-8385	procedures	_
50-12	8386-8390	from	_
50-13	8391-8393	Du	_
50-14	8394-8396	et	_
50-15	8397-8399	al	_
50-16	8400-8401	.	_

Text=(2012) in the main data set.
51-1	8402-8403	(	_
51-2	8404-8408	2012	_
51-3	8409-8410	)	_
51-4	8411-8413	in	_
51-5	8414-8417	the	_
51-6	8418-8422	main	_
51-7	8423-8427	data	_
51-8	8428-8431	set	_
51-9	8432-8433	.	_

Text=To assess between‐site generalizability by external validation, the predictive model built in the main data set was directly applied to the validated data set.
52-1	8434-8436	To	_
52-2	8437-8443	assess	_
52-3	8444-8456	between‐site	_
52-4	8457-8473	generalizability	_
52-5	8474-8476	by	_
52-6	8477-8485	external	_
52-7	8486-8496	validation	_
52-8	8497-8498	,	_
52-9	8499-8502	the	_
52-10	8503-8513	predictive	_
52-11	8514-8519	model	_
52-12	8520-8525	built	_
52-13	8526-8528	in	_
52-14	8529-8532	the	_
52-15	8533-8537	main	_
52-16	8538-8542	data	_
52-17	8543-8546	set	_
52-18	8547-8550	was	_
52-19	8551-8559	directly	_
52-20	8560-8567	applied	_
52-21	8568-8570	to	_
52-22	8571-8574	the	_
52-23	8575-8584	validated	_
52-24	8585-8589	data	_
52-25	8590-8593	set	_
52-26	8594-8595	.	_

Text=To establish transfer learning and to explore factors influencing between‐site generalizability, the unsupervised group independent component analysis (ICA) step was updated based on the two data sets and the between‐site generalizability was estimated again.
53-1	8596-8598	To	_
53-2	8599-8608	establish	_
53-3	8609-8617	transfer	_
53-4	8618-8626	learning	_
53-5	8627-8630	and	_
53-6	8631-8633	to	_
53-7	8634-8641	explore	_
53-8	8642-8649	factors	_
53-9	8650-8661	influencing	_
53-10	8662-8674	between‐site	_
53-11	8675-8691	generalizability	_
53-12	8692-8693	,	_
53-13	8694-8697	the	_
53-14	8698-8710	unsupervised	_
53-15	8711-8716	group	_
53-16	8717-8728	independent	_
53-17	8729-8738	component	_
53-18	8739-8747	analysis	_
53-19	8748-8749	(	_
53-20	8750-8753	ICA	_
53-21	8754-8755	)	_
53-22	8756-8760	step	_
53-23	8761-8764	was	_
53-24	8765-8772	updated	_
53-25	8773-8778	based	_
53-26	8779-8781	on	_
53-27	8782-8785	the	_
53-28	8786-8789	two	_
53-29	8790-8794	data	_
53-30	8795-8799	sets	_
53-31	8800-8803	and	_
53-32	8804-8807	the	_
53-33	8808-8820	between‐site	_
53-34	8821-8837	generalizability	_
53-35	8838-8841	was	_
53-36	8842-8851	estimated	_
53-37	8852-8857	again	_
53-38	8858-8859	.	_

Text=In general, the machine learning framework consisted of the following steps: (a) extracting and selecting the spatial components (features) for all participants; (b) identification of features with significant differences using a two‐sample t test with thresholding; (c) kernel principal component analysis (PCA); (d) Fisher linear discriminant (FLD) analysis on individual components; and (e) majority voting across components.
54-1	8860-8862	In	_
54-2	8863-8870	general	_
54-3	8871-8872	,	_
54-4	8873-8876	the	_
54-5	8877-8884	machine	_
54-6	8885-8893	learning	_
54-7	8894-8903	framework	_
54-8	8904-8913	consisted	_
54-9	8914-8916	of	_
54-10	8917-8920	the	_
54-11	8921-8930	following	_
54-12	8931-8936	steps	_
54-13	8937-8938	:	_
54-14	8939-8940	(	_
54-15	8941-8942	a	_
54-16	8943-8944	)	_
54-17	8945-8955	extracting	_
54-18	8956-8959	and	_
54-19	8960-8969	selecting	_
54-20	8970-8973	the	_
54-21	8974-8981	spatial	_
54-22	8982-8992	components	_
54-23	8993-8994	(	_
54-24	8995-9003	features	_
54-25	9004-9005	)	_
54-26	9006-9009	for	_
54-27	9010-9013	all	_
54-28	9014-9026	participants	_
54-29	9027-9028	;	_
54-30	9029-9030	(	_
54-31	9031-9032	b	_
54-32	9033-9034	)	_
54-33	9035-9049	identification	_
54-34	9050-9052	of	_
54-35	9053-9061	features	_
54-36	9062-9066	with	_
54-37	9067-9078	significant	_
54-38	9079-9090	differences	_
54-39	9091-9096	using	_
54-40	9097-9098	a	_
54-41	9099-9109	two‐sample	_
54-42	9110-9111	t	_
54-43	9112-9116	test	_
54-44	9117-9121	with	_
54-45	9122-9134	thresholding	_
54-46	9135-9136	;	_
54-47	9137-9138	(	_
54-48	9139-9140	c	_
54-49	9141-9142	)	_
54-50	9143-9149	kernel	_
54-51	9150-9159	principal	_
54-52	9160-9169	component	_
54-53	9170-9178	analysis	_
54-54	9179-9180	(	_
54-55	9181-9184	PCA	_
54-56	9185-9186	)	_
54-57	9187-9188	;	_
54-58	9189-9190	(	_
54-59	9191-9192	d	_
54-60	9193-9194	)	_
54-61	9195-9201	Fisher	_
54-62	9202-9208	linear	_
54-63	9209-9221	discriminant	_
54-64	9222-9223	(	_
54-65	9224-9227	FLD	_
54-66	9228-9229	)	_
54-67	9230-9238	analysis	_
54-68	9239-9241	on	_
54-69	9242-9252	individual	_
54-70	9253-9263	components	_
54-71	9264-9265	;	_
54-72	9266-9269	and	_
54-73	9270-9271	(	_
54-74	9272-9273	e	_
54-75	9274-9275	)	_
54-76	9276-9284	majority	_
54-77	9285-9291	voting	_
54-78	9292-9298	across	_
54-79	9299-9309	components	_
54-80	9310-9311	.	_

Text=Assessing within‐site generalizability Components originating from artifacts, motion, and respiratory/cardiac cycles, which were identified by considering how much regions known to be associated with these signals were represented in the components.
55-1	9312-9321	Assessing	_
55-2	9322-9333	within‐site	_
55-3	9334-9350	generalizability	_
55-4	9351-9361	Components	_
55-5	9362-9373	originating	_
55-6	9374-9378	from	_
55-7	9379-9388	artifacts	_
55-8	9389-9390	,	_
55-9	9391-9397	motion	_
55-10	9398-9399	,	_
55-11	9400-9403	and	_
55-12	9404-9423	respiratory/cardiac	_
55-13	9424-9430	cycles	_
55-14	9431-9432	,	_
55-15	9433-9438	which	_
55-16	9439-9443	were	_
55-17	9444-9454	identified	_
55-18	9455-9457	by	_
55-19	9458-9469	considering	_
55-20	9470-9473	how	_
55-21	9474-9478	much	_
55-22	9479-9486	regions	_
55-23	9487-9492	known	_
55-24	9493-9495	to	_
55-25	9496-9498	be	_
55-26	9499-9509	associated	_
55-27	9510-9514	with	_
55-28	9515-9520	these	_
55-29	9521-9528	signals	_
55-30	9529-9533	were	_
55-31	9534-9545	represented	_
55-32	9546-9548	in	_
55-33	9549-9552	the	_
55-34	9553-9563	components	_
55-35	9564-9565	.	_

Text=This included edges (motion, respiration), major arteries or veins, the circle of Willis, and the sagittal sinus (cardiac cycle) as well as regions in the vicinity of field inhomogeneity (movement by field inhomogeneity interaction effects).
56-1	9566-9570	This	_
56-2	9571-9579	included	_
56-3	9580-9585	edges	_
56-4	9586-9587	(	_
56-5	9588-9594	motion	_
56-6	9595-9596	,	_
56-7	9597-9608	respiration	_
56-8	9609-9610	)	_
56-9	9611-9612	,	_
56-10	9613-9618	major	_
56-11	9619-9627	arteries	_
56-12	9628-9630	or	_
56-13	9631-9636	veins	_
56-14	9637-9638	,	_
56-15	9639-9642	the	_
56-16	9643-9649	circle	_
56-17	9650-9652	of	_
56-18	9653-9659	Willis	_
56-19	9660-9661	,	_
56-20	9662-9665	and	_
56-21	9666-9669	the	_
56-22	9670-9678	sagittal	_
56-23	9679-9684	sinus	_
56-24	9685-9686	(	_
56-25	9687-9694	cardiac	_
56-26	9695-9700	cycle	_
56-27	9701-9702	)	_
56-28	9703-9705	as	_
56-29	9706-9710	well	_
56-30	9711-9713	as	_
56-31	9714-9721	regions	_
56-32	9722-9724	in	_
56-33	9725-9728	the	_
56-34	9729-9737	vicinity	_
56-35	9738-9740	of	_
56-36	9741-9746	field	_
56-37	9747-9760	inhomogeneity	_
56-38	9761-9762	(	_
56-39	9763-9771	movement	_
56-40	9772-9774	by	_
56-41	9775-9780	field	_
56-42	9781-9794	inhomogeneity	_
56-43	9795-9806	interaction	_
56-44	9807-9814	effects	_
56-45	9815-9816	)	_
56-46	9817-9818	.	_

Text=Components consisting of ventricles.
57-1	9819-9829	Components	_
57-2	9830-9840	consisting	_
57-3	9841-9843	of	_
57-4	9844-9854	ventricles	_
57-5	9855-9856	.	_

Text=Components that showed low and widespread activation.
58-1	9857-9867	Components	_
58-2	9868-9872	that	_
58-3	9873-9879	showed	_
58-4	9880-9883	low	_
58-5	9884-9887	and	_
58-6	9888-9898	widespread	_
58-7	9899-9909	activation	_
58-8	9910-9911	.	_

Text=In feature extraction and selection, spatial group ICA was first run based on the entire main data set.
59-1	9912-9914	In	_
59-2	9915-9922	feature	_
59-3	9923-9933	extraction	_
59-4	9934-9937	and	_
59-5	9938-9947	selection	_
59-6	9948-9949	,	_
59-7	9950-9957	spatial	_
59-8	9958-9963	group	_
59-9	9964-9967	ICA	_
59-10	9968-9971	was	_
59-11	9972-9977	first	_
59-12	9978-9981	run	_
59-13	9982-9987	based	_
59-14	9988-9990	on	_
59-15	9991-9994	the	_
59-16	9995-10001	entire	_
59-17	10002-10006	main	_
59-18	10007-10011	data	_
59-19	10012-10015	set	_
59-20	10016-10017	.	_

Text=Data for all participants were concatenated across time.
60-1	10018-10022	Data	_
60-2	10023-10026	for	_
60-3	10027-10030	all	_
60-4	10031-10043	participants	_
60-5	10044-10048	were	_
60-6	10049-10061	concatenated	_
60-7	10062-10068	across	_
60-8	10069-10073	time	_
60-9	10074-10075	.	_

Text=Then, PCA was used to reduce the data into 40 principal components at the participant level.
61-1	10076-10080	Then	_
61-2	10081-10082	,	_
61-3	10083-10086	PCA	_
61-4	10087-10090	was	_
61-5	10091-10095	used	_
61-6	10096-10098	to	_
61-7	10099-10105	reduce	_
61-8	10106-10109	the	_
61-9	10110-10114	data	_
61-10	10115-10119	into	_
61-11	10120-10122	40	_
61-12	10123-10132	principal	_
61-13	10133-10143	components	_
61-14	10144-10146	at	_
61-15	10147-10150	the	_
61-16	10151-10162	participant	_
61-17	10163-10168	level	_
61-18	10169-10170	.	_

Text=Afterward, ICA was performed to extract 30 independent spatial components based on the resulting data from the PCA at the group level.
62-1	10171-10180	Afterward	_
62-2	10181-10182	,	_
62-3	10183-10186	ICA	_
62-4	10187-10190	was	_
62-5	10191-10200	performed	_
62-6	10201-10203	to	_
62-7	10204-10211	extract	_
62-8	10212-10214	30	_
62-9	10215-10226	independent	_
62-10	10227-10234	spatial	_
62-11	10235-10245	components	_
62-12	10246-10251	based	_
62-13	10252-10254	on	_
62-14	10255-10258	the	_
62-15	10259-10268	resulting	_
62-16	10269-10273	data	_
62-17	10274-10278	from	_
62-18	10279-10282	the	_
62-19	10283-10286	PCA	_
62-20	10287-10289	at	_
62-21	10290-10293	the	_
62-22	10294-10299	group	_
62-23	10300-10305	level	_
62-24	10306-10307	.	_

Text=The analysis of spatial group ICA employed Infomax ICA (Bell & Sejnowski, 1995) in the GIFT software package for MATLAB (GIFT, 2011).
63-1	10308-10311	The	_
63-2	10312-10320	analysis	_
63-3	10321-10323	of	_
63-4	10324-10331	spatial	_
63-5	10332-10337	group	_
63-6	10338-10341	ICA	_
63-7	10342-10350	employed	_
63-8	10351-10358	Infomax	_
63-9	10359-10362	ICA	_
63-10	10363-10364	(	_
63-11	10365-10369	Bell	_
63-12	10370-10371	&	_
63-13	10372-10381	Sejnowski	_
63-14	10382-10383	,	_
63-15	10384-10388	1995	_
63-16	10389-10390	)	_
63-17	10391-10393	in	_
63-18	10394-10397	the	_
63-19	10398-10402	GIFT	_
63-20	10403-10411	software	_
63-21	10412-10419	package	_
63-22	10420-10423	for	_
63-23	10424-10430	MATLAB	_
63-24	10431-10432	(	_
63-25	10433-10437	GIFT	_
63-26	10438-10439	,	_
63-27	10440-10444	2011	_
63-28	10445-10446	)	_
63-29	10447-10448	.	_

Text=Second, the 16 spatial components were selected manually according to the exclusion criteria below: This step provided a template of spatial components to establish correspondence of components in the subsequent LOO ICA analysis.
64-1	10449-10455	Second	_
64-2	10456-10457	,	_
64-3	10458-10461	the	_
64-4	10462-10464	16	_
64-5	10465-10472	spatial	_
64-6	10473-10483	components	_
64-7	10484-10488	were	_
64-8	10489-10497	selected	_
64-9	10498-10506	manually	_
64-10	10507-10516	according	_
64-11	10517-10519	to	_
64-12	10520-10523	the	_
64-13	10524-10533	exclusion	_
64-14	10534-10542	criteria	_
64-15	10543-10548	below	_
64-16	10549-10550	:	_
64-17	10551-10555	This	_
64-18	10556-10560	step	_
64-19	10561-10569	provided	_
64-20	10570-10571	a	_
64-21	10572-10580	template	_
64-22	10581-10583	of	_
64-23	10584-10591	spatial	_
64-24	10592-10602	components	_
64-25	10603-10605	to	_
64-26	10606-10615	establish	_
64-27	10616-10630	correspondence	_
64-28	10631-10633	of	_
64-29	10634-10644	components	_
64-30	10645-10647	in	_
64-31	10648-10651	the	_
64-32	10652-10662	subsequent	_
64-33	10663-10666	LOO	_
64-34	10667-10670	ICA	_
64-35	10671-10679	analysis	_
64-36	10680-10681	.	_

Text=Then, LOO cross‐validation was used to separate the data into a test set (one participant) and a training set (the remaining sample) and group ICA was performed for the training data.
65-1	10682-10686	Then	_
65-2	10687-10688	,	_
65-3	10689-10692	LOO	_
65-4	10693-10709	cross‐validation	_
65-5	10710-10713	was	_
65-6	10714-10718	used	_
65-7	10719-10721	to	_
65-8	10722-10730	separate	_
65-9	10731-10734	the	_
65-10	10735-10739	data	_
65-11	10740-10744	into	_
65-12	10745-10746	a	_
65-13	10747-10751	test	_
65-14	10752-10755	set	_
65-15	10756-10757	(	_
65-16	10758-10761	one	_
65-17	10762-10773	participant	_
65-18	10774-10775	)	_
65-19	10776-10779	and	_
65-20	10780-10781	a	_
65-21	10782-10790	training	_
65-22	10791-10794	set	_
65-23	10795-10796	(	_
65-24	10797-10800	the	_
65-25	10801-10810	remaining	_
65-26	10811-10817	sample	_
65-27	10818-10819	)	_
65-28	10820-10823	and	_
65-29	10824-10829	group	_
65-30	10830-10833	ICA	_
65-31	10834-10837	was	_
65-32	10838-10847	performed	_
65-33	10848-10851	for	_
65-34	10852-10855	the	_
65-35	10856-10864	training	_
65-36	10865-10869	data	_
65-37	10870-10871	.	_

Text=In order to identify individual subject components, spatial–temporal reconstruction (Nickerson, Smith, Öngür, & Beckmann, 2017) based on the ICA model was used to obtain the spatial components for each participant in both the test and training data.
66-1	10872-10874	In	_
66-2	10875-10880	order	_
66-3	10881-10883	to	_
66-4	10884-10892	identify	_
66-5	10893-10903	individual	_
66-6	10904-10911	subject	_
66-7	10912-10922	components	_
66-8	10923-10924	,	_
66-9	10925-10941	spatial–temporal	_
66-10	10942-10956	reconstruction	_
66-11	10957-10958	(	_
66-12	10959-10968	Nickerson	_
66-13	10969-10970	,	_
66-14	10971-10976	Smith	_
66-15	10977-10978	,	_
66-16	10979-10984	Öngür	_
66-17	10985-10986	,	_
66-18	10987-10988	&	_
66-19	10989-10997	Beckmann	_
66-20	10998-10999	,	_
66-21	11000-11004	2017	_
66-22	11005-11006	)	_
66-23	11007-11012	based	_
66-24	11013-11015	on	_
66-25	11016-11019	the	_
66-26	11020-11023	ICA	_
66-27	11024-11029	model	_
66-28	11030-11033	was	_
66-29	11034-11038	used	_
66-30	11039-11041	to	_
66-31	11042-11048	obtain	_
66-32	11049-11052	the	_
66-33	11053-11060	spatial	_
66-34	11061-11071	components	_
66-35	11072-11075	for	_
66-36	11076-11080	each	_
66-37	11081-11092	participant	_
66-38	11093-11095	in	_
66-39	11096-11100	both	_
66-40	11101-11104	the	_
66-41	11105-11109	test	_
66-42	11110-11113	and	_
66-43	11114-11122	training	_
66-44	11123-11127	data	_
66-45	11128-11129	.	_

Text=A matching procedure based on correlation with the template of spatial components was used to establish component correspondence between the LOO splits.
67-1	11130-11131	A	_
67-2	11132-11140	matching	_
67-3	11141-11150	procedure	_
67-4	11151-11156	based	_
67-5	11157-11159	on	_
67-6	11160-11171	correlation	_
67-7	11172-11176	with	_
67-8	11177-11180	the	_
67-9	11181-11189	template	_
67-10	11190-11192	of	_
67-11	11193-11200	spatial	_
67-12	11201-11211	components	_
67-13	11212-11215	was	_
67-14	11216-11220	used	_
67-15	11221-11223	to	_
67-16	11224-11233	establish	_
67-17	11234-11243	component	_
67-18	11244-11258	correspondence	_
67-19	11259-11266	between	_
67-20	11267-11270	the	_
67-21	11271-11274	LOO	_
67-22	11275-11281	splits	_
67-23	11282-11283	.	_

Text=Then, a voxel‐wise two‐sample t test between the two groups for the training data was conducted to order the voxel in terms of their t‐test value/significance to obtain maximally discriminative features.
68-1	11284-11288	Then	_
68-2	11289-11290	,	_
68-3	11291-11292	a	_
68-4	11293-11303	voxel‐wise	_
68-5	11304-11314	two‐sample	_
68-6	11315-11316	t	_
68-7	11317-11321	test	_
68-8	11322-11329	between	_
68-9	11330-11333	the	_
68-10	11334-11337	two	_
68-11	11338-11344	groups	_
68-12	11345-11348	for	_
68-13	11349-11352	the	_
68-14	11353-11361	training	_
68-15	11362-11366	data	_
68-16	11367-11370	was	_
68-17	11371-11380	conducted	_
68-18	11381-11383	to	_
68-19	11384-11389	order	_
68-20	11390-11393	the	_
68-21	11394-11399	voxel	_
68-22	11400-11402	in	_
68-23	11403-11408	terms	_
68-24	11409-11411	of	_
68-25	11412-11417	their	_
68-26	11418-11424	t‐test	_
68-27	11425-11443	value/significance	_
68-28	11444-11446	to	_
68-29	11447-11453	obtain	_
68-30	11454-11463	maximally	_
68-31	11464-11478	discriminative	_
68-32	11479-11487	features	_
68-33	11488-11489	.	_

Text=Only voxels with t values larger than a threshold t 0 proceeded to the next step.
69-1	11490-11494	Only	_
69-2	11495-11501	voxels	_
69-3	11502-11506	with	_
69-4	11507-11508	t	_
69-5	11509-11515	values	_
69-6	11516-11522	larger	_
69-7	11523-11527	than	_
69-8	11528-11529	a	_
69-9	11530-11539	threshold	_
69-10	11540-11541	t	_
69-11	11542-11543	0	_
69-12	11544-11553	proceeded	_
69-13	11554-11556	to	_
69-14	11557-11560	the	_
69-15	11561-11565	next	_
69-16	11566-11570	step	_
69-17	11571-11572	.	_

Text=The threshold t 0 was determined such that the class separation in the final FLD step was maximal within the training data set.
70-1	11573-11576	The	_
70-2	11577-11586	threshold	_
70-3	11587-11588	t	_
70-4	11589-11590	0	_
70-5	11591-11594	was	_
70-6	11595-11605	determined	_
70-7	11606-11610	such	_
70-8	11611-11615	that	_
70-9	11616-11619	the	_
70-10	11620-11625	class	_
70-11	11626-11636	separation	_
70-12	11637-11639	in	_
70-13	11640-11643	the	_
70-14	11644-11649	final	_
70-15	11650-11653	FLD	_
70-16	11654-11658	step	_
70-17	11659-11662	was	_
70-18	11663-11670	maximal	_
70-19	11671-11677	within	_
70-20	11678-11681	the	_
70-21	11682-11690	training	_
70-22	11691-11695	data	_
70-23	11696-11699	set	_
70-24	11700-11701	.	_

Text=When the final threshold value (t 0) was determined, the threshold was applied to the test data.
71-1	11702-11706	When	_
71-2	11707-11710	the	_
71-3	11711-11716	final	_
71-4	11717-11726	threshold	_
71-5	11727-11732	value	_
71-6	11733-11734	(	_
71-7	11735-11736	t	_
71-8	11737-11738	0	_
71-9	11739-11740	)	_
71-10	11741-11744	was	_
71-11	11745-11755	determined	_
71-12	11756-11757	,	_
71-13	11758-11761	the	_
71-14	11762-11771	threshold	_
71-15	11772-11775	was	_
71-16	11776-11783	applied	_
71-17	11784-11786	to	_
71-18	11787-11790	the	_
71-19	11791-11795	test	_
71-20	11796-11800	data	_
71-21	11801-11802	.	_

Text=Subsequently, the spatial components for the test and training data were decomposed by kernel PCA.
72-1	11803-11815	Subsequently	_
72-2	11816-11817	,	_
72-3	11818-11821	the	_
72-4	11822-11829	spatial	_
72-5	11830-11840	components	_
72-6	11841-11844	for	_
72-7	11845-11848	the	_
72-8	11849-11853	test	_
72-9	11854-11857	and	_
72-10	11858-11866	training	_
72-11	11867-11871	data	_
72-12	11872-11876	were	_
72-13	11877-11887	decomposed	_
72-14	11888-11890	by	_
72-15	11891-11897	kernel	_
72-16	11898-11901	PCA	_
72-17	11902-11903	.	_

Text=Finally, the test and training data were projected to one dimension by Fisher's linear discriminant analysis (LDA) to make a final prediction of the test label.
73-1	11904-11911	Finally	_
73-2	11912-11913	,	_
73-3	11914-11917	the	_
73-4	11918-11922	test	_
73-5	11923-11926	and	_
73-6	11927-11935	training	_
73-7	11936-11940	data	_
73-8	11941-11945	were	_
73-9	11946-11955	projected	_
73-10	11956-11958	to	_
73-11	11959-11962	one	_
73-12	11963-11972	dimension	_
73-13	11973-11975	by	_
73-14	11976-11982	Fisher	_
73-15	11983-11985	's	_
73-16	11986-11992	linear	_
73-17	11993-12005	discriminant	_
73-18	12006-12014	analysis	_
73-19	12015-12016	(	_
73-20	12017-12020	LDA	_
73-21	12021-12022	)	_
73-22	12023-12025	to	_
73-23	12026-12030	make	_
73-24	12031-12032	a	_
73-25	12033-12038	final	_
73-26	12039-12049	prediction	_
73-27	12050-12052	of	_
73-28	12053-12056	the	_
73-29	12057-12061	test	_
73-30	12062-12067	label	_
73-31	12068-12069	.	_

Text=After feature extraction and selection, classification was done for each of the 16 components independently and then combined by majority voting to make a final decision on the classification of each test sample.
74-1	12070-12075	After	_
74-2	12076-12083	feature	_
74-3	12084-12094	extraction	_
74-4	12095-12098	and	_
74-5	12099-12108	selection	_
74-6	12109-12110	,	_
74-7	12111-12125	classification	_
74-8	12126-12129	was	_
74-9	12130-12134	done	_
74-10	12135-12138	for	_
74-11	12139-12143	each	_
74-12	12144-12146	of	_
74-13	12147-12150	the	_
74-14	12151-12153	16	_
74-15	12154-12164	components	_
74-16	12165-12178	independently	_
74-17	12179-12182	and	_
74-18	12183-12187	then	_
74-19	12188-12196	combined	_
74-20	12197-12199	by	_
74-21	12200-12208	majority	_
74-22	12209-12215	voting	_
74-23	12216-12218	to	_
74-24	12219-12223	make	_
74-25	12224-12225	a	_
74-26	12226-12231	final	_
74-27	12232-12240	decision	_
74-28	12241-12243	on	_
74-29	12244-12247	the	_
74-30	12248-12262	classification	_
74-31	12263-12265	of	_
74-32	12266-12270	each	_
74-33	12271-12275	test	_
74-34	12276-12282	sample	_
74-35	12283-12284	.	_

Text=The classification procedure in Du et al.
75-1	12285-12288	The	_
75-2	12289-12303	classification	_
75-3	12304-12313	procedure	_
75-4	12314-12316	in	_
75-5	12317-12319	Du	_
75-6	12320-12322	et	_
75-7	12323-12325	al	_
75-8	12326-12327	.	_

Text='s (2012) study also reported the classification rates for combinations of components that achieved a high accuracy.
76-1	12328-12330	's	_
76-2	12331-12332	(	_
76-3	12333-12337	2012	_
76-4	12338-12339	)	_
76-5	12340-12345	study	_
76-6	12346-12350	also	_
76-7	12351-12359	reported	_
76-8	12360-12363	the	_
76-9	12364-12378	classification	_
76-10	12379-12384	rates	_
76-11	12385-12388	for	_
76-12	12389-12401	combinations	_
76-13	12402-12404	of	_
76-14	12405-12415	components	_
76-15	12416-12420	that	_
76-16	12421-12429	achieved	_
76-17	12430-12431	a	_
76-18	12432-12436	high	_
76-19	12437-12445	accuracy	_
76-20	12446-12447	.	_

Text=However, as this selection procedure might lead to biased classification rates, we only considered classification results based on majority voting across all selected components in the present study.
77-1	12448-12455	However	_
77-2	12456-12457	,	_
77-3	12458-12460	as	_
77-4	12461-12465	this	_
77-5	12466-12475	selection	_
77-6	12476-12485	procedure	_
77-7	12486-12491	might	_
77-8	12492-12496	lead	_
77-9	12497-12499	to	_
77-10	12500-12506	biased	_
77-11	12507-12521	classification	_
77-12	12522-12527	rates	_
77-13	12528-12529	,	_
77-14	12530-12532	we	_
77-15	12533-12537	only	_
77-16	12538-12548	considered	_
77-17	12549-12563	classification	_
77-18	12564-12571	results	_
77-19	12572-12577	based	_
77-20	12578-12580	on	_
77-21	12581-12589	majority	_
77-22	12590-12596	voting	_
77-23	12597-12603	across	_
77-24	12604-12607	all	_
77-25	12608-12616	selected	_
77-26	12617-12627	components	_
77-27	12628-12630	in	_
77-28	12631-12634	the	_
77-29	12635-12642	present	_
77-30	12643-12648	study	_
77-31	12649-12650	.	_

Text=Assessing between‐site generalizability To assess between‐site generalizability by external validation, the template of spatial components which was used to select features in assessing within‐site generalizability was applied to the validated set of rsfMRI data.
78-1	12651-12660	Assessing	_
78-2	12661-12673	between‐site	_
78-3	12674-12690	generalizability	_
78-4	12691-12693	To	_
78-5	12694-12700	assess	_
78-6	12701-12713	between‐site	_
78-7	12714-12730	generalizability	_
78-8	12731-12733	by	_
78-9	12734-12742	external	_
78-10	12743-12753	validation	_
78-11	12754-12755	,	_
78-12	12756-12759	the	_
78-13	12760-12768	template	_
78-14	12769-12771	of	_
78-15	12772-12779	spatial	_
78-16	12780-12790	components	_
78-17	12791-12796	which	_
78-18	12797-12800	was	_
78-19	12801-12805	used	_
78-20	12806-12808	to	_
78-21	12809-12815	select	_
78-22	12816-12824	features	_
78-23	12825-12827	in	_
78-24	12828-12837	assessing	_
78-25	12838-12849	within‐site	_
78-26	12850-12866	generalizability	_
78-27	12867-12870	was	_
78-28	12871-12878	applied	_
78-29	12879-12881	to	_
78-30	12882-12885	the	_
78-31	12886-12895	validated	_
78-32	12896-12899	set	_
78-33	12900-12902	of	_
78-34	12903-12909	rsfMRI	_
78-35	12910-12914	data	_
78-36	12915-12916	.	_

Text=The spatial components for each participant in the validated data set were obtained through spatial–temporal reconstruction based on the template which was built from the main data set.
79-1	12917-12920	The	_
79-2	12921-12928	spatial	_
79-3	12929-12939	components	_
79-4	12940-12943	for	_
79-5	12944-12948	each	_
79-6	12949-12960	participant	_
79-7	12961-12963	in	_
79-8	12964-12967	the	_
79-9	12968-12977	validated	_
79-10	12978-12982	data	_
79-11	12983-12986	set	_
79-12	12987-12991	were	_
79-13	12992-13000	obtained	_
79-14	13001-13008	through	_
79-15	13009-13025	spatial–temporal	_
79-16	13026-13040	reconstruction	_
79-17	13041-13046	based	_
79-18	13047-13049	on	_
79-19	13050-13053	the	_
79-20	13054-13062	template	_
79-21	13063-13068	which	_
79-22	13069-13072	was	_
79-23	13073-13078	built	_
79-24	13079-13083	from	_
79-25	13084-13087	the	_
79-26	13088-13092	main	_
79-27	13093-13097	data	_
79-28	13098-13101	set	_
79-29	13102-13103	.	_

Text=In this setting, determination of the threshold t 0, kernel PCA and training of the LDA classifier considered only the main data set (training set), and hence the identified classification model was directly applied to the validated data set without any adaptation.
80-1	13104-13106	In	_
80-2	13107-13111	this	_
80-3	13112-13119	setting	_
80-4	13120-13121	,	_
80-5	13122-13135	determination	_
80-6	13136-13138	of	_
80-7	13139-13142	the	_
80-8	13143-13152	threshold	_
80-9	13153-13154	t	_
80-10	13155-13156	0	_
80-11	13157-13158	,	_
80-12	13159-13165	kernel	_
80-13	13166-13169	PCA	_
80-14	13170-13173	and	_
80-15	13174-13182	training	_
80-16	13183-13185	of	_
80-17	13186-13189	the	_
80-18	13190-13193	LDA	_
80-19	13194-13204	classifier	_
80-20	13205-13215	considered	_
80-21	13216-13220	only	_
80-22	13221-13224	the	_
80-23	13225-13229	main	_
80-24	13230-13234	data	_
80-25	13235-13238	set	_
80-26	13239-13240	(	_
80-27	13241-13249	training	_
80-28	13250-13253	set	_
80-29	13254-13255	)	_
80-30	13256-13257	,	_
80-31	13258-13261	and	_
80-32	13262-13267	hence	_
80-33	13268-13271	the	_
80-34	13272-13282	identified	_
80-35	13283-13297	classification	_
80-36	13298-13303	model	_
80-37	13304-13307	was	_
80-38	13308-13316	directly	_
80-39	13317-13324	applied	_
80-40	13325-13327	to	_
80-41	13328-13331	the	_
80-42	13332-13341	validated	_
80-43	13342-13346	data	_
80-44	13347-13350	set	_
80-45	13351-13358	without	_
80-46	13359-13362	any	_
80-47	13363-13373	adaptation	_
80-48	13374-13375	.	_

Text=Apart from changing the LOO cross‐validation to cross‐sample validation, all classification parameters and procedures remained identical.
81-1	13376-13381	Apart	_
81-2	13382-13386	from	_
81-3	13387-13395	changing	_
81-4	13396-13399	the	_
81-5	13400-13403	LOO	_
81-6	13404-13420	cross‐validation	_
81-7	13421-13423	to	_
81-8	13424-13436	cross‐sample	_
81-9	13437-13447	validation	_
81-10	13448-13449	,	_
81-11	13450-13453	all	_
81-12	13454-13468	classification	_
81-13	13469-13479	parameters	_
81-14	13480-13483	and	_
81-15	13484-13494	procedures	_
81-16	13495-13503	remained	_
81-17	13504-13513	identical	_
81-18	13514-13515	.	_

Text=To further explore factors influencing between‐site generalizability, we updated the ICA step to consider data from both sites.
82-1	13516-13518	To	_
82-2	13519-13526	further	_
82-3	13527-13534	explore	_
82-4	13535-13542	factors	_
82-5	13543-13554	influencing	_
82-6	13555-13567	between‐site	_
82-7	13568-13584	generalizability	_
82-8	13585-13586	,	_
82-9	13587-13589	we	_
82-10	13590-13597	updated	_
82-11	13598-13601	the	_
82-12	13602-13605	ICA	_
82-13	13606-13610	step	_
82-14	13611-13613	to	_
82-15	13614-13622	consider	_
82-16	13623-13627	data	_
82-17	13628-13632	from	_
82-18	13633-13637	both	_
82-19	13638-13643	sites	_
82-20	13644-13645	.	_

Text=To achieve this, we identified 30 spatially independent components across both data sets using group ICA and established correspondence to the template components from the within‐site generalization procedure using spatial correlation.
83-1	13646-13648	To	_
83-2	13649-13656	achieve	_
83-3	13657-13661	this	_
83-4	13662-13663	,	_
83-5	13664-13666	we	_
83-6	13667-13677	identified	_
83-7	13678-13680	30	_
83-8	13681-13690	spatially	_
83-9	13691-13702	independent	_
83-10	13703-13713	components	_
83-11	13714-13720	across	_
83-12	13721-13725	both	_
83-13	13726-13730	data	_
83-14	13731-13735	sets	_
83-15	13736-13741	using	_
83-16	13742-13747	group	_
83-17	13748-13751	ICA	_
83-18	13752-13755	and	_
83-19	13756-13767	established	_
83-20	13768-13782	correspondence	_
83-21	13783-13785	to	_
83-22	13786-13789	the	_
83-23	13790-13798	template	_
83-24	13799-13809	components	_
83-25	13810-13814	from	_
83-26	13815-13818	the	_
83-27	13819-13830	within‐site	_
83-28	13831-13845	generalization	_
83-29	13846-13855	procedure	_
83-30	13856-13861	using	_
83-31	13862-13869	spatial	_
83-32	13870-13881	correlation	_
83-33	13882-13883	.	_

Text=The matching procedure involved calculating the pairwise spatial correlation between all 30 estimated components and the 16 template components.
84-1	13884-13887	The	_
84-2	13888-13896	matching	_
84-3	13897-13906	procedure	_
84-4	13907-13915	involved	_
84-5	13916-13927	calculating	_
84-6	13928-13931	the	_
84-7	13932-13940	pairwise	_
84-8	13941-13948	spatial	_
84-9	13949-13960	correlation	_
84-10	13961-13968	between	_
84-11	13969-13972	all	_
84-12	13973-13975	30	_
84-13	13976-13985	estimated	_
84-14	13986-13996	components	_
84-15	13997-14000	and	_
84-16	14001-14004	the	_
84-17	14005-14007	16	_
84-18	14008-14016	template	_
84-19	14017-14027	components	_
84-20	14028-14029	.	_

Text=Then, pairs of components that exhibited the highest absolute correlation were sequentially matched to identify all 16 components in the joint data set.
85-1	14030-14034	Then	_
85-2	14035-14036	,	_
85-3	14037-14042	pairs	_
85-4	14043-14045	of	_
85-5	14046-14056	components	_
85-6	14057-14061	that	_
85-7	14062-14071	exhibited	_
85-8	14072-14075	the	_
85-9	14076-14083	highest	_
85-10	14084-14092	absolute	_
85-11	14093-14104	correlation	_
85-12	14105-14109	were	_
85-13	14110-14122	sequentially	_
85-14	14123-14130	matched	_
85-15	14131-14133	to	_
85-16	14134-14142	identify	_
85-17	14143-14146	all	_
85-18	14147-14149	16	_
85-19	14150-14160	components	_
85-20	14161-14163	in	_
85-21	14164-14167	the	_
85-22	14168-14173	joint	_
85-23	14174-14178	data	_
85-24	14179-14182	set	_
85-25	14183-14184	.	_

Text=After this matching procedure, the components were visually inspected to confirm that they represented the same brain regions as the template.
86-1	14185-14190	After	_
86-2	14191-14195	this	_
86-3	14196-14204	matching	_
86-4	14205-14214	procedure	_
86-5	14215-14216	,	_
86-6	14217-14220	the	_
86-7	14221-14231	components	_
86-8	14232-14236	were	_
86-9	14237-14245	visually	_
86-10	14246-14255	inspected	_
86-11	14256-14258	to	_
86-12	14259-14266	confirm	_
86-13	14267-14271	that	_
86-14	14272-14276	they	_
86-15	14277-14288	represented	_
86-16	14289-14292	the	_
86-17	14293-14297	same	_
86-18	14298-14303	brain	_
86-19	14304-14311	regions	_
86-20	14312-14314	as	_
86-21	14315-14318	the	_
86-22	14319-14327	template	_
86-23	14328-14329	.	_

Text=Importantly, in this setting, the validated data set was only considered in the training of the group ICA model and hence no label information from the validated data set was used in feature extraction or fitting of the classification model.
87-1	14330-14341	Importantly	_
87-2	14342-14343	,	_
87-3	14344-14346	in	_
87-4	14347-14351	this	_
87-5	14352-14359	setting	_
87-6	14360-14361	,	_
87-7	14362-14365	the	_
87-8	14366-14375	validated	_
87-9	14376-14380	data	_
87-10	14381-14384	set	_
87-11	14385-14388	was	_
87-12	14389-14393	only	_
87-13	14394-14404	considered	_
87-14	14405-14407	in	_
87-15	14408-14411	the	_
87-16	14412-14420	training	_
87-17	14421-14423	of	_
87-18	14424-14427	the	_
87-19	14428-14433	group	_
87-20	14434-14437	ICA	_
87-21	14438-14443	model	_
87-22	14444-14447	and	_
87-23	14448-14453	hence	_
87-24	14454-14456	no	_
87-25	14457-14462	label	_
87-26	14463-14474	information	_
87-27	14475-14479	from	_
87-28	14480-14483	the	_
87-29	14484-14493	validated	_
87-30	14494-14498	data	_
87-31	14499-14502	set	_
87-32	14503-14506	was	_
87-33	14507-14511	used	_
87-34	14512-14514	in	_
87-35	14515-14522	feature	_
87-36	14523-14533	extraction	_
87-37	14534-14536	or	_
87-38	14537-14544	fitting	_
87-39	14545-14547	of	_
87-40	14548-14551	the	_
87-41	14552-14566	classification	_
87-42	14567-14572	model	_
87-43	14573-14574	.	_

Text=Apart from the different templates of spatial components, the classification procedure was identical to the within‐site generalization setting.
88-1	14575-14580	Apart	_
88-2	14581-14585	from	_
88-3	14586-14589	the	_
88-4	14590-14599	different	_
88-5	14600-14609	templates	_
88-6	14610-14612	of	_
88-7	14613-14620	spatial	_
88-8	14621-14631	components	_
88-9	14632-14633	,	_
88-10	14634-14637	the	_
88-11	14638-14652	classification	_
88-12	14653-14662	procedure	_
88-13	14663-14666	was	_
88-14	14667-14676	identical	_
88-15	14677-14679	to	_
88-16	14680-14683	the	_
88-17	14684-14695	within‐site	_
88-18	14696-14710	generalization	_
88-19	14711-14718	setting	_
88-20	14719-14720	.	_

Text=The significance of the classification performance was assessed using a random permutation test in all settings where an empirical null distribution was obtained by applying an identical classification procedure to the data with permutated class labels.
89-1	14721-14724	The	_
89-2	14725-14737	significance	_
89-3	14738-14740	of	_
89-4	14741-14744	the	_
89-5	14745-14759	classification	_
89-6	14760-14771	performance	_
89-7	14772-14775	was	_
89-8	14776-14784	assessed	_
89-9	14785-14790	using	_
89-10	14791-14792	a	_
89-11	14793-14799	random	_
89-12	14800-14811	permutation	_
89-13	14812-14816	test	_
89-14	14817-14819	in	_
89-15	14820-14823	all	_
89-16	14824-14832	settings	_
89-17	14833-14838	where	_
89-18	14839-14841	an	_
89-19	14842-14851	empirical	_
89-20	14852-14856	null	_
89-21	14857-14869	distribution	_
89-22	14870-14873	was	_
89-23	14874-14882	obtained	_
89-24	14883-14885	by	_
89-25	14886-14894	applying	_
89-26	14895-14897	an	_
89-27	14898-14907	identical	_
89-28	14908-14922	classification	_
89-29	14923-14932	procedure	_
89-30	14933-14935	to	_
89-31	14936-14939	the	_
89-32	14940-14944	data	_
89-33	14945-14949	with	_
89-34	14950-14960	permutated	_
89-35	14961-14966	class	_
89-36	14967-14973	labels	_
89-37	14974-14975	.	_

